Literature DB >> 20809880

The co-occurrence of nonaffective psychosis and the pervasive developmental disorders: a systematic review.

Fiona E Padgett1, Eleni Miltsiou, Paul A Tiffin.   

Abstract

BACKGROUND: Pervasive developmental disorders (PDDs) were originally conceptualised as a form of ("infantile") psychosis. Recently, the disorders have been viewed as separate constructs. However, there is evidence of overlapping psychopathology, pathophysiology, and occurrence of the two syndromes.
METHODS: A historical overview is provided. A systematic search strategy was then used to identify literature relating to the co-occurrence of PDD and nonaffective psychosis.
RESULTS: The methodology and estimated rates of psychosis occurring in PDD varied dramatically, and few conclusions could be drawn due to the level of heterogeneity and selection bias in the populations studied. However, there were indications from the literature that rates of comorbid PDD were elevated in adolescents affected by juvenile-onset psychosis but the methodology was insufficiently robust to estimate a pooled prevalence.
CONCLUSIONS: There is some evidence for elevated rates of comorbid PDD in individuals with childhood-onset psychosis. Further work is needed in order to understand the potential mechanisms underlying such co-occurrence and how such affected individuals can be best supported.

Entities:  

Mesh:

Year:  2010        PMID: 20809880     DOI: 10.3109/13668250.2010.494596

Source DB:  PubMed          Journal:  J Intellect Dev Disabil        ISSN: 1366-8250


  9 in total

1.  Comparison of children with autism spectrum disorder with and without schizophrenia spectrum traits: gender, season of birth, and mental health risk factors.

Authors:  Kenneth D Gadow; Carla J DeVincent
Journal:  J Autism Dev Disord       Date:  2012-11

2.  What causes psychosis? An umbrella review of risk and protective factors.

Authors:  Joaquim Radua; Valentina Ramella-Cravaro; John P A Ioannidis; Abraham Reichenberg; Nacharin Phiphopthatsanee; Taha Amir; Hyi Yenn Thoo; Dominic Oliver; Cathy Davies; Craig Morgan; Philip McGuire; Robin M Murray; Paolo Fusar-Poli
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

3.  Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response.

Authors:  L Eugene Arnold; Kenneth D Gadow; Cristan A Farmer; Robert L Findling; Oscar Bukstein; Brooke S G Molina; Nicole V Brown; Xiaobai Li; E Victoria Rundberg-Rivera; Srihari Bangalore; Kristin Buchan-Page; Elizabeth A Hurt; Robert Rice; Nora K McNamara; Michael G Aman
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04       Impact factor: 2.576

4.  The 'at-risk mental state' for psychosis in adolescents: clinical presentation, transition and remission.

Authors:  Patrick Welsh; Paul A Tiffin
Journal:  Child Psychiatry Hum Dev       Date:  2014-02

5.  Prevalence of long-term health conditions in adults with autism: observational study of a whole country population.

Authors:  Ewelina Rydzewska; Laura Anne Hughes-McCormack; Christopher Gillberg; Angela Henderson; Cecilia MacIntyre; Julie Rintoul; Sally-Ann Cooper
Journal:  BMJ Open       Date:  2018-09-01       Impact factor: 2.692

6.  Autistic Symptoms in Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis.

Authors:  Franco De Crescenzo; Valentina Postorino; Martina Siracusano; Assia Riccioni; Marco Armando; Paolo Curatolo; Luigi Mazzone
Journal:  Front Psychiatry       Date:  2019-02-21       Impact factor: 4.157

7.  Association testing of copy number variants in schizophrenia and autism spectrum disorders.

Authors:  Bernard J Crespi; Helen J Crofts
Journal:  J Neurodev Disord       Date:  2012-05-30       Impact factor: 4.025

8.  Psychiatric Comorbidities in Children With ASD: Autism Centre Experience.

Authors:  Iva Ivanović
Journal:  Front Psychiatry       Date:  2021-06-09       Impact factor: 4.157

9.  Autistic traits in psychotic disorders: prevalence, familial risk, and impact on social functioning.

Authors:  Tim B Ziermans; Frederike Schirmbeck; Floor Oosterwijk; Hilde M Geurts; Lieuwe de Haan
Journal:  Psychol Med       Date:  2020-03-10       Impact factor: 7.723

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.